Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 5, 2006, Pages 518-529

  Hess, Allan D ^a   Thoburn, Christopher J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Autoreactive T cells; Fas FasL interaction; Major histocompatibility complex class II invariant chain peptide; Regulatory T cells; Syngeneic graft versus host disease

Indexed keywords

CD4 ANTIGEN; CYCLOSPORIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; APOPTOSIS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLOSPORINE; CYTOKINES; FAS LIGAND PROTEIN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RADIATION CHIMERA; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELF TOLERANCE; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, ISOGENEIC; TUMOR NECROSIS FACTORS;

EID: 33745433327     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.01.007     Document Type: Article

References (36)

1. Glazier A., Tutschka P.J., Farmer E.R., et al. GVHD in CsA treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 158 (1983) 1-12
2. Hess A.D., and Thoburn C.J. Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-vs-host disease. Immunol Rev 157 (1997) 111-123
3. Chen W., Thoburn C., and Hess A.D. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-vs-host disease. J Immunol 161 (1998) 7040-7046
4. Thoburn C.J., Miura Y., Bright E.C., et al. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease. Biol Blood Marrow Transplant 10 (2004) 591-603
5. Hess A.D., Thoburn C.J., and Horwitz L. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-vs-host disease. Transplantation 65 (1998) 785-792
6. Teshima T., Reddy P., Liu C., et al. Impaired negative selection causes autoimmune graft-versus-host disease. Blood 102 (2003) 429-435
7. Tivol E., Komorowkski R., and Drobyski W.R. Emergent autoimmunity in graft-versus-host disease. Blood 105 (2005) 4885-4891
8. Fischer A.C., Beschorner W.E., and Hess A.D. Requirements for the induction and adoptive transfer of syngeneic GVHD. J Exp Med 169 (1989) 1031-1038
9. + T cells prevent skin autoimmunity during chronic autologous graft-versus-host disease. Int J Transplant 4 (2004) 872-878
10. Hess A.D., Fischer A.C., Horwitz L., et al. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporine-induced syngeneic graft-vs-host disease. J Immunol 153 (1994) 400-411
11. Wu D.Y., and Goldschneider I. Cyclosporin-induced autologous graft-vs-host disease. a prototypical model of autoimmunity and active (dominant) tolerance coordinately expressed induced by recent thymic emigrants. J Immunol 162 (1999) 6926-6933
12. Miura Y., Thoburn C.J., Bright E.C., et al. Association of Foxp3 gene expression with graft-versus-host disease. Blood 104 (2004) 2187-2193
13. Hess A.D., Thoburn C., Chen W., et al. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen. Clin Immunol 101 (2001) 67-76
14. Hess A.D., Thoburn C.J., Miura Y., et al. Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen. Clin Immunol 114 (2005) 307-319
15. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
16. + T regulatory cells. Nat Immunol 4 (2003) 337-342
17. Shevach E. Regulatory T cells in autoimmunity. Ann Rev Immunol 18 (2000) 423-449
18. + regulatory T cells. Curr Opin Immunol 13 (2001) 644-649
19. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann Rev Immunol 22 (2004) 531-562
20. Kronenberg M., and Rudensky A. Regulation of immunity by self-reactive T cells. Nature 435 (2005) 598-604
21. Ben-Nunn A.H., Wekerle H., and Cohen H. Vaccination against autoimmune encephalomyelitis with a T lymphocyte line reactive against myelin basic protein. Nature 292 (1981) 60-64
22. Acha-Orbea H., Mitchell T.J., and Timmerman L. Limited heterogeneity of the T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54 (1988) 263-271
23. Gutierrez-Ramos J.C., Andrew J.L., and Moreno Alboran I. Insights into autoimmunity; from classical models to current perspectives. Immunol Rev 118 (1990) 73-84
24. + immunoregulatory T cells. central players in the arena of peripheral tolerance. Semin Immunol 16 (2004) 81-88
25. Hess A.D., Thoburn C.J., Chen W., et al. Complexity of effector mechanisms in syngeneic graft-vs-host disease. Biol Blood Marrow Transplant 6 (2000) 13-24
26. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance. regulatory T cell development and the forkhead transcription factor Foxp3. Nat Immunol 6 (2005) 331-337
27. Fischer A.C., and Hess A.D. Age related factors in cyclosporine-induced syngeneic graft-versus-host disease. regulatory role of marrow-derived lymphocytes. J Exp Med 172 (1990) 85-94
28. Beschorner W.E., Ren H., Phillips J., et al. Recovery of thymic microenvironment after cyclosporine prevents syngeneic graft-vs-host disease. Transplantation 52 (1991) 668-674
29. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev 3 (2003) 199-210
30. Graca L., Chen T.-C., Le Moine A., et al. Dominant tolerance. activation thresholds for peripheral generation of regulatory T cells. Trends Immunol 26 (2005) 130-135
31. + T cell receptors. Immunity 21 (2004) 267-277
32. Rohn T.A., Boes M., Wolters D., et al. Upregulation of the CLIP self-peptide on mature dendritic cells antagonizes T helper type 1 polarization. Nat Immunol 5 (2004) 909-918
33. Kasai M., Kropshofer H., Vogt A., et al. CLIP-derived self-peptides bound to MHC class II molecules of medullary thymic epithelial cells differ from those of cortical thymic epithelial cells in their diversity, length and C-terminal processing. Eur J Immunol 30 (2000) 3542-3551
34. Tutschka P.J., Ki P., Beschorner W.E., et al. Suppressor cells in transplantation tolerance, II. maturation of suppressor cells in the bone marrow chimera. Transplantation 32 (1985) 321-329
35. Kupiec-Weglinski J.W., Filho Strom T.B., and Tilney N.L. Sparing of suppressor cells; a critical action of cyclosporine. Transplantation 38 (1983) 97-104
36. Hess A.D. Chronic graft-versus-host disease. a breakdown of self-tolerance?. Blood 105 (2005) 4548-4549